Literature DB >> 32822737

Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

J J Schlezinger1, H Puckett2, J Oliver2, G Nielsen2, W Heiger-Bernays2, T F Webster2.   

Abstract

Humans are exposed to per- and polyfluoroalkyl substances (PFAS) in their drinking water, food, air, dust, and by direct use of consumer products. Increased concentrations of serum total cholesterol and low density lipoprotein cholesterol are among the endpoints best supported by epidemiology. The objectives of this study were to generate a new model for examining PFAS-induced dyslipidemia and to conduct molecular studies to better define mechanism(s) of action. We tested the hypothesis that perfluorooctanoic acid (PFOA) exposure at a human-relevant level dysregulates expression of genes controlling cholesterol homeostasis in livers of mice expressing human PPARα (hPPARα). Female and male hPPARα and PPARα null mice were fed a diet based on the "What we eat in America" analysis and exposed to PFOA in drinking water (8 μM) for 6 weeks. This resulted in a serum PFOA concentration of 48 μg/ml. PFOA increased liver mass, which was associated with histologically-evident lipid accumulation. Pooled analyses of serum lipoprotein cholesterol suggest that PFOA increased serum cholesterol, particularly in male mice. PFOA induced PPARα and constitutive androstane receptor target gene expression in liver. Expression of genes in four pathways regulating cholesterol homeostasis were also measured. PFOA decreased expression of Hmgcr in a PPARα-dependent manner. PFOA decreased expression of Ldlr and Cyp7a1 in a PPARα-independent manner. Apob expression was not changed. Sex differences were evident. This novel study design (hPPARα mice, American diet, long term exposure) generated new insight on the effects of PFOA on cholesterol regulation in the liver and the role of hPPARα.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholesterol; Constitutive androstane receptor; Perfluorooctanoic acid; Peroxisome proliferator activated receptor α

Mesh:

Substances:

Year:  2020        PMID: 32822737      PMCID: PMC7503133          DOI: 10.1016/j.taap.2020.115204

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  88 in total

1.  Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis.

Authors:  Keiichirou Morimura; Connie Cheung; Jerrold M Ward; Janardan K Reddy; Frank J Gonzalez
Journal:  Carcinogenesis       Date:  2005-12-24       Impact factor: 4.944

2.  Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.

Authors:  Stephanie J Frisbee; Anoop Shankar; Sarah S Knox; Kyle Steenland; David A Savitz; Tony Fletcher; Alan M Ducatman
Journal:  Arch Pediatr Adolesc Med       Date:  2010-09

3.  Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis.

Authors:  David L M van der Meer; Tatjana Degenhardt; Sami Väisänen; Philip J de Groot; Merja Heinäniemi; Sacco C de Vries; Michael Müller; Carsten Carlberg; Sander Kersten
Journal:  Nucleic Acids Res       Date:  2010-01-27       Impact factor: 16.971

4.  The association between PFOA, PFOS and serum lipid levels in adolescents.

Authors:  Sarah Dee Geiger; Jie Xiao; Alan Ducatman; Stephanie Frisbee; Kim Innes; Anoop Shankar
Journal:  Chemosphere       Date:  2013-11-13       Impact factor: 7.086

Review 5.  PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.

Authors:  Frank J Gonzalez; Yatrik M Shah
Journal:  Toxicology       Date:  2007-10-07       Impact factor: 4.221

6.  Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor alpha, but not human PPARalpha.

Authors:  Toshiki Nakamura; Yuki Ito; Yukie Yanagiba; Doni Hikmat Ramdhan; Yasuhide Kono; Hisao Naito; Yumi Hayashi; Yufei Li; Toshifumi Aoyama; Frank J Gonzalez; Tamie Nakajima
Journal:  Toxicology       Date:  2009-09-12       Impact factor: 4.221

7.  Strain and sex differences in serum cholesterol levels of mice.

Authors:  J H BRUELL; A F DAROCZY; H K HELLERSTEIN
Journal:  Science       Date:  1962-03-23       Impact factor: 47.728

8.  Evaluation of perfluoroalkyl acid activity using primary mouse and human hepatocytes.

Authors:  Mitchell B Rosen; Kaberi P Das; Carmen R Wood; Cynthia J Wolf; Barbara D Abbott; Christopher Lau
Journal:  Toxicology       Date:  2013-04-06       Impact factor: 4.221

9.  Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility.

Authors:  Kate Hoffman; Thomas F Webster; Scott M Bartell; Marc G Weisskopf; Tony Fletcher; Verónica M Vieira
Journal:  Environ Health Perspect       Date:  2010-10-04       Impact factor: 9.031

10.  Nuclear receptors HNF4α and LRH-1 cooperate in regulating Cyp7a1 in vivo.

Authors:  Serkan Kir; Yuan Zhang; Robert D Gerard; Steven A Kliewer; David J Mangelsdorf
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

View more
  15 in total

1.  Predicting the effects of per- and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro.

Authors:  Greylin Nielsen; Wendy J Heiger-Bernays; Jennifer J Schlezinger; Thomas F Webster
Journal:  Toxicology       Date:  2021-11-04       Impact factor: 4.221

2.  Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).

Authors:  Sung Kyun Park; Xin Wang; Ning Ding; Carrie A Karvonen-Gutierrez; Antonia M Calafat; William H Herman; Bhramar Mukherjee; Siobán D Harlow
Journal:  Diabetologia       Date:  2022-04-11       Impact factor: 10.460

3.  Perfluorooctanesulfonic Acid and Perfluorohexanesulfonic Acid Alter the Blood Lipidome and the Hepatic Proteome in a Murine Model of Diet-Induced Obesity.

Authors:  Marisa Pfohl; Lishann Ingram; Emily Marques; Adam Auclair; Benjamin Barlock; Rohitash Jamwal; Dwight Anderson; Brian S Cummings; Angela L Slitt
Journal:  Toxicol Sci       Date:  2020-12-01       Impact factor: 4.849

4.  Early-life associations between per- and polyfluoroalkyl substances and serum lipids in a longitudinal birth cohort.

Authors:  Annelise J Blomberg; Yu-Hsuan Shih; Carmen Messerlian; Louise Helskov Jørgensen; Pál Weihe; Philippe Grandjean
Journal:  Environ Res       Date:  2021-05-31       Impact factor: 8.431

Review 5.  Endocrine-disrupting chemicals and breastfeeding duration: a review.

Authors:  Rachel Criswell; Kathryn A Crawford; Hana Bucinca; Megan E Romano
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2020-12       Impact factor: 3.626

6.  Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes.

Authors:  Emily Marques; Marisa Pfohl; Wei Wei; Giuseppe Tarantola; Lucie Ford; Ogochukwu Amaeze; Jessica Alesio; Sangwoo Ryu; Xuelian Jia; Hao Zhu; Geoffrey D Bothun; Angela Slitt
Journal:  Toxicol Appl Pharmacol       Date:  2022-03-23       Impact factor: 4.460

Review 7.  Legacy and Emerging Per- and Polyfluoroalkyl Substances: Analytical Techniques, Environmental Fate, and Health Effects.

Authors:  Richard A Brase; Elizabeth J Mullin; David C Spink
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

Review 8.  Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease.

Authors:  Julie Massart; Karima Begriche; Anne Corlu; Bernard Fromenty
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

9.  Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; T Hyötyläinen; T Sinioja; C Boston; H Puckett; J Oliver; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2021-07-10       Impact factor: 4.460

Review 10.  Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research.

Authors:  Suzanne E Fenton; Alan Ducatman; Alan Boobis; Jamie C DeWitt; Christopher Lau; Carla Ng; James S Smith; Stephen M Roberts
Journal:  Environ Toxicol Chem       Date:  2020-12-07       Impact factor: 4.218

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.